MOACM
IRWD icon

Mutual of America Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Mutual of America Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,332
Closed -$94.5K – 1427
2024
Q4 		$94.5K Buy
21,332
+189
+0.9% +$767 ﹤0.01% 1431
2024
Q3 		$87.1K Sell
21,143
-1,849
-8% -$9.94K ﹤0.01% 1443
2024
Q2 		$150K Sell
22,992
-678
-3% -$4.8K ﹤0.01% 1421
2024
Q1 		$206K Sell
23,670
-378
-2% -$4.59K ﹤0.01% 1411
2023
Q4 		$275K Sell
24,048
-16
-0.1% -$158 ﹤0.01% 1332
2023
Q3 		$232K Sell
24,064
-2,333
-9% -$22.9K ﹤0.01% 1336
2023
Q2 		$281K Sell
26,397
-1,085
-4% -$11.7K ﹤0.01% 1312
2023
Q1 		$289K Sell
27,482
-486
-2% -$5.44K ﹤0.01% 1298
2022
Q4 		$347K Buy
27,968
+1,446
+5% +$16.4K ﹤0.01% 1219
2022
Q3 		$275K Buy
26,522
+684
+3% +$7.75K ﹤0.01% 1262
2022
Q2 		$298K Buy
+25,838
New +$304K ﹤0.01% 1201

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Mutual of America Capital Management's IRWD Position: Q1 2025 in Review

Mutual of America Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 21,332 shares — an estimated $94.5K sold.

Mutual of America Capital Management first reported a position in IRWD in Q2 2022 and held it in 11 quarters. The position peaked at $347K in Q4 2022. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Mutual of America Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Mutual of America Capital Management sold 21,332 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $94.5K.
  • Mutual of America Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • Mutual of America Capital Management's Ironwood Pharmaceuticals position peaked at $347K in Q4 2022.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Mutual of America Capital Management's 13F filing for Q1 2025, filed 1 May 2025.